The AWARrD Team


Essam Othman MD, University of Assiut. AWARrD Principal Investigator

Dr Othman is an Associate Professor in the Department of Obstetrics and Gynecology of Assiut University in Assiut Egypt. He is the  Principal Investigator of the AWARrD Project. A reproductive endocrinologist, he has performed basic research on the development of leiomyomas in the uterus and is an involved clinician, educator and administrator in his department. He is responsible for all aspects of the AWARrD project.

Karim Abdallah Ph.D, University of Assiut. AIM (Project 1)

Dr Abdallah is

Radwa Abdelhamid Ph.D, University of Assiut. AIM (Project 1)


DrAbdelhamid is

Mean Adly Ph.D, University of Assiut. AIM (Project 1)

Dr Adly is

Ayman Al-Hendy MD, Ph.D, Project Lead, University of Chicago

AIM (Project 1)

Dr Al-Hendy is a gynecologist and Professor Professor and Vice Chair forResearch in the Department of Obstetrics and Gynecology at The University of Chicago with current or prior funding from 8 NIH institutes/Centers (NICHD, NIEHS, NCRR, NIMH, NCATS, NIMHD, ODS, OWHR), USDA, and over 27 commercial and pharmaceutical research contracts. He has served on several NIH study sections and special emphasis panels,and has been the chair of the NIH/CSR Integrative Clinical Endocrinology and Reproduction (ICER) IRG 2014-2016. Dr. Al-Hendy and co-workers were first to report serum vitamin D deficiency as a risk factor for uterine fibroids in 2010, pivotal findings confirmed later by other groups worldwide (more than 40 published articles from 23 countries) and present a biochemical explanation for the ethnic disparity of this common disease. Dr. Al-Hendy will also identify and recruit suitable cases of traditional (typical) leiomyoma versus atypical leiomyoma as well as leiomyosarcoma suspicious cases. He will also work closely with the data science experts to map out suspicious areas on MRI scans that will then be used to feed the machine leanings algorithms.


Kirollos Bandry Ph.D, University of Assiut. AIM (Project 1)

Dr Bandry is

Kirollos Bandry Ph.D, University of Assiut. AIM (Project 1)

Dr Bandry is

Moumen El-Melegy Ph.D, University of Assiut. AIM (Project 1)

Dr El-Melegy is

Ghada Elsayed MD, University of Assiut. Co-Principal Investigator, DatAUB; Site PI for the Assiut Val-IDA-te pilot study

Dr Elsayed is a hematologist and Assistant Professor in the Department of Medicine at Assiut University in Assiut Egypt. Dr. Elsayed is a senior practicing hematologist with special expertise in iron deficiency anemia in reproductive age women. She has a long history of successful conduct of basic and clinical research with a focus on iron deficiency anemia and menstrual disorders both in Egypt and during her collaborative work with Mayo Clinic in Rochester, Minnesota, USA. Dr. Elsayed will serve as the Core Lead for DatAUB (Project 2) of the AWARrD hub at Assiut University, Assiut, Egypt and will serve as the site PI for the Val-IDA-te pilot study.


Ibrahim Elsemman Ph.D, University of Assiut. AIM (Project 1)

Dr Elsemman is

Abdulla Hamed, University of Assiut. AWARrD Administrator

New Paragraph

Maryellen Giger Ph.D, Project Co-Investigator, University of Chicago. AIM (Project 1)

Dr Giger is the the A.N. Pritzker Professor of Radiology and Medical Physics at The University of Chicago. She is an internationally-recognized expert in computerized quantitative image analysis and AI of medical images, especially in women health. Dr. Giger will have the primary scientific responsibility and oversight for the UChicago AI/radiomics of uterine cancer, and will work with all Co-Investigators on this proposal.


Siobàn Harlow Ph.D, University of Michigan. Consultant: DatAUB (Project 2)


Dr Harlow  is the

Carla Harmath MD, Co-Investigator, University of Chicago.

AIM (Project 1)

Dr Harmath is an Assistant Professor in the Department of Radiology at the University of Chicago. She is fellowship-trained in body imaging/MRI and is faculty in the Section of Abdominal Imaging at the University of Chicago.On this project, Dr. Harmath will have the primary responsibility for the radiologist assessment of the uterine MRIs, including delineation of fibroids/tumors. Dr. Harmath will also work closely with the other investigators in the interpretation of AI outputs


Sara Hassanian Ph.D, University of Assiut. AIM (Project 1)

Dr Hassanian is

Hui Li Ph.D, Co-Investigator, University of Chicago. AIM (Project 1)

Dr His is a Research Associate Professor in the Department of Radiology at The University of Chicago. Dr. Li has been working with Dr. Giger for over 15 years and has expertise in medical image analyses and in statistical evaluations for robustness and reproducibility assessments. Dr. Li will work with Dr. Giger on the radiomic feature analysis and deep learning of fibroid lesions on MRI.


Anna Klepchukova, MD. Flo Health, Dat-AUB (Project 2)


Dr Klepchukova is the Medical Director for Flo Health

Sandra Laveaux MD, University of Chicago. AIM (Project 1)

Dr Laveaux is an Assistant Professor in the Department of Obstetrics & Gynecology at the University of Chicago.is an Assistant Professor in the Department of Obstetrics and Gynecology at The

University of Chicago. Dr. Madueke-Laveaux specializes in the medical and surgical treatment of abnormal uterine bleeding, uterine fibroids, endometriosis and chronic pelvic pain.  On this project, Dr. Madueke-Laveaux will provide access to and assist in identifying suitable cases of traditional leiomyoma versus atypical leiomyoma as well as leiomyosarcoma suspicious cases. She will also work closely with the data science experts to map out suspicious areas on MRI scans that will then be used to feed the machine leanings algorithms.

Michelle Lavin MD, Ph.D, Royal College of Surgeons, Ireland. Consultant: DatAUB (Project 2)

Dr Lavin is the

Mary Ann Lumsden MD, Ph.D, FIGO Co-Investigator DatAUB (Project 2).

Professor Lumsden is the Executive Director of FIGO (the International Federation of Gynecology and Obstetrics) headquartered in London UK as well as a Voluntary Professor at the Department of Obstetrics & Gynecology at the University of Glasgow in Scotland. An experienced clinical investigator,Dr. Lumsden will assist Dr. Munrowith the day-to-day management of the Dat-AUB project and will advise and work with Dr. Ghada Elsayed from

Assiut (Core Lead).


Kristen Matteson MD, MPH, Brown University. Consultant: DatAUB (Project 2)

Dr Matteson is the

Malcolm G. Munro MD, FRCSC, FIGO. That-PLEASE Study Chair; Co-Investigator, DatAUB

Dr Munro is the Chair of FIGO's Menstrual Disorders Committee and a Clinical Professor in the Department of Obstetrics & Gynecology at the University of California, Los Angeles. Dr Munro was instrumental in the organizational development of the FIGO Menstrual Disorders Committee (MDC) and its systems for categorizing symptoms and causes of AUB are used worldwide. He has substantial experience in managing international teams of clinicians and in the design and management of multinational research. Dr Munro has published extensively on abnormal uterine bleeding and advised Flo Health on the development of their tool for estimating the volume of menstrual bleeding.


Marawan Radwan, University of Assiut. AWARrD Core

Dr Radwan is

Mostafa Salem, University of Assiut. AWARrD Core

Dr Radwan is

Gehan Seifeldein Ph.D, University of Assiut. AIM (Project 1)

Dr Seifeldein

Katsiaryna Shkodzik, MD. Flo Health, Dat-AUB (Project 2)


Dr Shkodzik is 

Taysir Solimon, Ph.D Hub Assiut Egypt


Dr. SolimonThe.

Rick L Stevens  Ph.D, University of Chicago. DatAUB (Project 2)

Dr Stevens is the Associate Laboratory Director of the Computing, Environment and Life Sciences Directorate at Argonne National Laboratory, and a Professor of Computer Science at the University of Chicago, with significant responsibility in delivering on the U.S. national initiative for Exascale computing and developingthe DOE initiative in Artificial Intelligence (AI) for Science. He is a member of the American Association for the Advancement of Science and has received many national honors for his research, including an R&D 100 award.

Professor Stevens will be responsible for the overall project management, scientific direction, and all other aspects of the project.


Joseph Vaughn, MD. Brother Andre Site PI (Kenya) and Co-Investigator, DatAUB (Project 2)

Dr Vaughn is a hematologist who is on the staff of the Brother Andre Medical Center in Dandora/Nairobi Kenya. Dr. Vaughn will be responsible for all aspects of the project at BAMC, programmatic and financial. He will oversee the activities of all personnel, prepare all required reports, and evaluate and disseminate research data and resources generated during the grant period. He will lead recruitment efforts, data collection, analysis and

interpretation.


Fangfang Xia, Ph.D University of Chicago, Dat-AUB (Project 2)

Computer Scientist in the Data Science and Learning Division at Argonne National Laboratory. He will assist Professor Stevens on implementation of strategies that facilitate coordination with the projects, implementation of strategies that foster data sharing, and will help implement strategies and provide regular guidance to the Graduate Research

Assistant (GRA) on data quality assurance and quality control methods.


Liudmila Zhaunova, Ph.D Flo Health, Dat-AUB (Project 2)


Dr Zhaunova is the Scientific Lead for Flo Health and is the key liaison between Flo and the DatAUB project. She will be involved in the day to day management of the Flo relationship and will facilitate interaction amongst the data scientists at the University of Assiut, the University of Chicago, and Flo health.



Share by: